Evidence map›Paper›PMID 40125173›Full record

ReviewCureus2025

Screening Mammography and Artificial Intelligence: A Comprehensive Systematic Review.

Enas Abu Abeelh, Zain Abuabeileh

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Enas Abu AbeelhRadiology, Primary Health Care Corporation, Doha, QAT.
Zain AbuabeilehRadiology, King Hussein Cancer Center, Amman, JOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening mammography is vital for early breast cancer detection, improving outcomes by identifying malignancies at treatable stages. Artificial intelligence has emerged as a tool to enhance diagnostic accuracy and reduce radiologists' workload in screening programs, though its full integration into clinical practice remains limited, necessitating a comprehensive review of its performance. This systematic review assesses artificial intelligence's effectiveness in screening mammography, focusing on diagnostic performance, reduction of false positives, and support for radiologists in clinical decision-making. A systematic search was conducted across PubMed, Embase, Web of Science, Cochrane Central, and Scopus for studies published between 2013 and 2024, including those evaluating artificial intelligence in mammography screening and reporting outcomes related to cancer detection, sensitivity, specificity, and workflow optimization. A total of 13 studies were analyzed, with data extracted on study characteristics, population demographics, artificial intelligence algorithms, and key outcomes. Artificial intelligence-assisted readings in screening mammography were found to be comparable or superior to traditional double readings by radiologists, reducing unnecessary recalls, improving specificity, and in some cases increasing cancer detection rates. Its integration into workflows showed potential for reducing radiologist workload while maintaining high diagnostic performance; however, challenges such as high false-positive rates and variations in artificial intelligence performance across patient subgroups remain concerns. Overall, artificial intelligence has the potential to enhance the efficiency and accuracy of breast cancer screening programs, and while it can reduce unnecessary recalls and alleviate radiologists' workloads, issues with false positives and demographic variations in accuracy highlight the need for further research. With ongoing refinement, artificial intelligence could become a valuable tool in routine mammography screening, augmenting radiologists' capabilities and improving patient care.

Indexed as

ai-assisted diagnosisartificial intelligencebreast cancercancer detectionscreening mammography

Identifiers

PMID40125173
PMCPMC11929143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.